Clinical Trials
16 trialsNCT07607327 2026-05-26
FORWARD
CareDx
Not yet recruiting
NCT07561385 2026-05-01
Dresden MDS Registry With an Accompanying Biomaterial Collection
Technische Universität Dresden
Not yet recruiting
NCT07511829 2026-04-06
WATCH Tranfuse
University of Oxford
Recruiting
NCT06906380 2025-12-08
A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
ARCE Therapeutics, Inc.
Not yet recruiting
NCT06111612 2024-07-22
Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Recruiting
NCT04142372 2024-04-24
HemaTMA
Tampere University Hospital
Active not recruiting
NCT02338479 2023-02-08
Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
Center for International Blood and Marrow Transplant Research
Unknown
NCT05154474 2022-05-03
SPACE2
Weprom
Unknown
NCT04517175 2020-08-18
Could Ki-67 be Used as a Diagnostic or Prognostic Marker in Hemato-oncological Diagnostics?
Maastricht University
Unknown
NCT01146210 2016-05-17
Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
Children's Oncology Group
Completed
NCT01904175 2016-05-05
Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant
Duke University
Completed
NCT00511537 2013-08-02
Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders
University of California, San Francisco
Completed
NCT00513318 2013-08-02
Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies
University of California, San Francisco
Terminated
NCT01463410 2013-05-29
Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
Skyline Diagnostics BV
Terminated
NCT00513175 2012-11-09
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
University of California, San Francisco
Completed
NCT00195533 2009-11-16
Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
Wyeth is now a wholly owned subsidiary of Pfizer
Completed